(Q37692647)

22 August 2017

1 reference

title

Liver, liver cell and stem cell transplantation for the treatment of urea cycle defects (English)

1 reference

stem cell transplantation

22 August 2017

1 reference

Jochen Meyburg

1

1 reference

PubMed ID

20156696

22 August 2017

Georg F Hoffmann

series ordinal

2

1 reference

22 August 2017

29 January 2010

1 reference

Molecular Genetics and Metabolism

22 August 2017

1 reference

22 August 2017

100 Suppl 1

1 reference

22 August 2017

S77-83

1 reference

Survival after treatment with phenylacetate and benzoate for urea-cycle disorders

22 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Long-term outcome of patients with urea cycle disorders and the question of neonatal screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Urea cycle defects: management and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21-year, multicentre study of acute hyperammonaemic episodes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Cognitive outcome in urea cycle disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Liver transplantation for ornithine transcarbamylase deficiency in a girl

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Persistent acitrullinemia after liver transplantation for carbamylphosphate synthetase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Liver transplantation for the treatment of urea cycle disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

The role of liver transplantation in urea cycle disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Liver transplantation in urea cycle disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Liver transplantation for citrullinaemia improves intellectual function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Distinctly abnormal brain metabolism in late-onset ornithine transcarbamylase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

High urgency liver transplantation in ornithine transcarbamylase deficiency presenting with acute liver failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Developmental outcomes with early orthotopic liver transplantation for infants with neonatal-onset urea cycle defects and a female patient with late-onset ornithine transcarbamylase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Treatment of ornithine transcarbamylase deficiency in girls by auxiliary liver transplantation: conceptual changes in a living-donor program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Feasibility of auxiliary partial orthotopic liver transplantation from living donors for patients with adult-onset type II citrullinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Pediatric liver transplantation for metabolic liver disease: experience at King's College Hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

A pediatric patient with classical citrullinemia who underwent living-related partial liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Transplantation of human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Hepatocyte transplantation followed by auxiliary liver transplantation--a novel treatment for ornithine transcarbamylase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Cryopreserved liver cell transplantation controls ornithine transcarbamylase deficient patient while awaiting liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Human hepatocyte transplantation: worldwide results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

One liver for four children: first clinical series of liver cell transplantation for severe neonatal urea cycle defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Hepatocyte transplantation as a treatment for glycogen storage disease type 1a.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Correction of an inborn error of metabolism by intraportal hepatocyte transplantation in a dog model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Intraportal hepatocyte transplantation in the pig: hemodynamic and histopathological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Hepatocyte transplantation for inherited factor VII deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Hepatocyte transplantation. Advancing biology and treating children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Liver after hepatocyte transplantation for liver-based metabolic disorders in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Intraportal infusion of 99mtechnetium-macro-aggregrated albumin particles and hepatocytes in rabbits: assessment of shunting and portal hemodynamic changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Rapid clearance of transplanted hepatocytes from pulmonary capillaries in rats indicates a wide safety margin of liver repopulation and the potential of using surrogate albumin particles for safety analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Hepatocyte transplantation in acute liver failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Liver cell transplantation for the treatment of inborn errors of metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Large-scale isolation of human hepatocytes for therapeutic application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Study of hepatocyte differentiation using embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Repopulation of athymic mouse liver by cryopreserved early human fetal hepatoblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Adult-Derived Human Liver Mesenchymal-Like Cells as a Potential Progenitor Reservoir of Hepatocytes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Different types of liver progenitor cells and their niches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Human cord blood stem cells generate human cytokeratin 18-negative hepatocyte-like cells in injured mouse liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Hepatogenic differentiation of human mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Teratoma formation and hepatocyte differentiation in mouse liver transplanted with mouse embryonic stem cell-derived embryoid bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Human monocyte-derived neohepatocytes: a promising alternative to primary human hepatocytes for autologous cell therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Present status and perspectives of cell-based therapies for liver diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Kinetics of liver repopulation after bone marrow transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Myelomonocytic cells are sufficient for therapeutic cell fusion in liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Hepatocyte transplantation in animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Management of hyperbilirubinemia in biliary atresia by hepatic progenitor cell transplantation through hepatic artery: a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

Treatment of Crigler-Najjar Syndrome type 1 by hepatic progenitor cell transplantation: a simple procedure for management of hyperbilirubinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.01.011

10.1016/J.YMGME.2010.01.011

7 January 2021

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20156696